Qingming Zhu - Concepedia

Author

Qingming Zhu

Novartis (United States)

Also Known As

Qingming Zhu

Publications

368

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (China)Novartis (Switzerland)

About

Qingming Zhu is an author at Novartis (United States) specializing in medicine, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	281
2	Natural Sciences	4	4	107
3	Biochemistry	3	3	92
4	Health Sciences	2	2	174
5	Engineering	1	1	40

Qingming Zhu

Publications

353

Citations

H-Index

Page 1

	Year	Citations
Discovery of LFF571: An Investigational Agent for <i>Clostridium difficile</i> Infection Matthew J. LaMarche, Jennifer A. Leeds, Adam Amaral, Journal of Medicinal Chemistry Bioorganic ChemistryBacteriophageInvestigational AgentBacterial PathogensPharmaceutical Chemistry	2012	116
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228 Folkert Reck, Alun Bermingham, Johanne Blais, Bioorganic & Medicinal Chemistry Letters Antimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial Resistance Gene	2018	58
Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D Erik L. Meredith, Kimberly Beattie, Robin Burgis, Journal of Medicinal Chemistry Heart MorphologyCardiac MuscleHeart FailureDrug TargetChemical Biology	2010	41
General Synthesis of Racemic Me<sub>2</sub>Si-Bridged Bis(indenyl) Zirconocene Complexes Xingwang Zhang, Qingming Zhu, Ilia A. Guzei, Journal of the American Chemical Society Inorganic ChemistryChemical EngineeringEngineeringZirconocene Complexesxingwang ZhangCoordination Complex	2000	40
Identification of Mutations in the <i>mrdA</i> Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in <i>ftsI</i> (PBP3) and Which Carry <i>bla</i> <sub>NDM-1</sub> Srijan Ranjitkar, Folkert Reck, Xiaobo Ke, mSphere	2019	32
3,5-Diarylazoles as novel and selective inhibitors of protein kinase D Gabriel G. Gamber, Erik L. Meredith, Qingming Zhu, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2011	28
Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors Sharad Verma, Dhanapalan Nagarathnam, Jianxing Shao, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2005	23
Phylogenetic and Biological Significance of Evolutionary Elements from Metazoan Mitochondrial Genomes Jianbo Yuan, Qingming Zhu, Bin Liu PLoS ONE GeneticsLiving SpeciesGenomicsBiological SignificancePhylogenetic Analysis	2014	15

Page 1